Next Article in Journal
Epigenetic Regulation of EMT (Epithelial to Mesenchymal Transition) and Tumor Aggressiveness: A View on Paradoxical Roles of KDM6B and EZH2
Previous Article in Journal
How to Design a Whole-Genome Bisulfite Sequencing Experiment
Previous Article in Special Issue
Molecular and Epigenetic Mechanisms Underlying Cognitive and Adaptive Responses to Stress

Non-CpG Methylation Revised

Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena, 324-00161 Rome, Italy
Epigenomes 2018, 2(4), 22;
Received: 30 November 2018 / Accepted: 11 December 2018 / Published: 12 December 2018
(This article belongs to the Special Issue Epigenetics of the Nervous System)
Textbook and scientific papers addressing DNA methylation usually still cite “DNA methylation occurs at CpG cytosines”. Methylation at cytosines outside the CpG nucleotide, the so-called “non-CpG methylation”, is usually considered a minor and not biologically relevant process. However, the technical improvements and additional studies in epigenetics have demonstrated that non-CpG methylation is present with frequency higher than previously thought and retains biological activity, potentially relevant to the understanding and the treatment of human diseases. View Full-Text
Keywords: DNA methylation; non-CpG methylation; DNMT3; bisulfite assay; neuroepigenetics DNA methylation; non-CpG methylation; DNMT3; bisulfite assay; neuroepigenetics
MDPI and ACS Style

Fuso, A. Non-CpG Methylation Revised. Epigenomes 2018, 2, 22.

AMA Style

Fuso A. Non-CpG Methylation Revised. Epigenomes. 2018; 2(4):22.

Chicago/Turabian Style

Fuso, Andrea. 2018. "Non-CpG Methylation Revised" Epigenomes 2, no. 4: 22.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop